Leon Chen, PhD
InvestorPartner at The Column Group
Find your path to Leon
28 people in our graph share verified history with Leon — schools, employers, funds. One of them is your warm intro.
Tim KutzkeyunlockedLeon: together at The Column Group
×11Leon: together at The Column Group
About
Leon Chen is a founder-turned-VC who led KAI Pharmaceuticals to an Amgen acquisition with approved drug Parsabiv and serves as a hands-on interim executive and board chair for technical platform biotechs.
Invests in
BiotechHealthtech
Colleagues at The Column Group
Aadit Shah
Principal at The Column Group
Arnav Mehta, MD, PhD
Venture Partner at The Column Group
Carla Daniel
Partner at The Column Group
Craig Parker
Venture Partner at The Column Group
David Goeddel
Managing Partner at The Column Group
David V. Goeddel, Ph.D.
General Partner at The Column Group
David V. Goeddel, PhD
Partner Emeritus at The Column Group
Hui Tian
Partner at The Column Group
Frequently asked questions
- Who is Leon Chen, PhD?
- Leon Chen is a founder-turned-VC who led KAI Pharmaceuticals to an Amgen acquisition with approved drug Parsabiv and serves as a hands-on interim executive and board chair for technical platform biotechs.
- Where does Leon Chen, PhD work?
- Leon Chen, PhD is Partner at The Column Group.
- What does Leon Chen, PhD invest in?
- Leon Chen, PhD invests in Biotech, Healthtech.